PolarityTE Inc
NASDAQ:PTE
PolarityTE Inc
NASDAQ:PTE
Price:
0.0666 USD
Market Closed
Updated:
May 7, 2024
PolarityTE Inc
Revenue
|
PolarityTE Inc
Revenue Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
PolarityTE Inc
NASDAQ:PTE
|
Revenue
$814k
|
CAGR 3-Years
-48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$29.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
19%
|
PolarityTE Inc
Revenue Breakdown
Breakdown by Geography
PolarityTE Inc
PolarityTE Inc
Not Available
Breakdown by Segments
PolarityTE Inc
PolarityTE Inc
|
Total Revenue:
814k
USD
|
|
Contract Services:
814k
USD
|
|
Preclinical Research Services:
814k
USD
|
|
Service:
814k
USD
|
See Also
What is PolarityTE Inc's Revenue?
Revenue
814k
USD
814k
USD
Based on the financial report for Dec 31, 2022, PolarityTE Inc's Revenue amounts to 814k USD.
What is PolarityTE Inc's Revenue growth rate?
Revenue CAGR 3Y
-48%
-48%
Over the last year, the Revenue growth was -91%. The average annual Revenue growth rates for PolarityTE Inc have been -48% over the past three years .
You don't have any saved screeners yet
